OPC Pharmaceutical Joint Stock Company
OPC Pharmaceutical Joint Stock Company, commonly referred to as OPC Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1976, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on prescription medications and over-the-counter solutions. With a strong operational presence across various regions in Vietnam, OPC Pharma is renowned for its commitment to innovation and quality. The company offers a diverse range of core products, including generic drugs and herbal medicines, distinguished by their efficacy and safety. OPC Pharma's dedication to research and development has positioned it as a leader in the Vietnamese market, earning accolades for its contributions to healthcare and patient well-being.
DitchCarbon Score
How does OPC Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPC Pharmaceutical Joint Stock Company's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OPC Pharmaceutical Joint Stock Company's reported carbon emissions
OPC Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). Without specific climate pledges or reduction strategies, OPC Pharmaceutical's approach to carbon emissions remains unclear. As the company does not inherit emissions data from a parent organisation, all information is based solely on its own reporting. In the context of the pharmaceutical industry, it is essential for companies to develop and communicate clear climate commitments to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OPC Pharmaceutical Joint Stock Company is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
